Citation Impact
Citing Papers
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
2009
HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
2009
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel In Vivo Model of Acquired Cetuximab Resistance
2011
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
2009
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
2012 Standout
Lapatinib and breast cancer: current indications and outlook for the future
2010
Gastric cancer
2016 Standout
Head and neck squamous cell carcinoma
2020 Standout
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
2015
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
2015
The biology and management of non-small cell lung cancer
2018 StandoutNature
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Antibody-targeted drugs and drug resistance—Challenges and solutions
2014
Cancer drug resistance: an evolving paradigm
2013 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
2012
Cancer stem cells revisited
2017 Standout
Colorectal cancer
2013 Standout
The molecular biology of head and neck cancer
2010 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
2014
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
2011
Targeting apoptosis in cancer therapy
2020 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
2013
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription
2012
Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control Centers
2013
Unmet needs and challenges in gastric cancer: The way forward
2014
c-Met Expression Is a Marker of Poor Prognosis in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Chemoradiation
2014
Ki67 expression in breast cancer
2016 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Photochemical internalization of tumor-targeted protein toxins
2011
Src signaling in cancer invasion
2010
Metastatic colonization by circulating tumour cells
2016 StandoutNature
High chromosomal instability in brain metastases of colorectal carcinoma
2010
Strategies and challenges for the next generation of therapeutic antibodies
2010
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Head and Neck Cancer
2020 Standout
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
2014
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Activated HGF-c-Met Axis in Head and Neck Cancer
2017
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
2010
Waste disposal—An attractive strategy for cancer therapy
2017 Science
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
2015
Chemotherapy for advanced gastric cancer
2017 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
2010
microRNA: A Master Regulator of Cellular Processes for Bioengineering Systems
2010
Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
2010
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
New photosensitizers for photodynamic therapy
2016 Standout
Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer
2013
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
2019
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Drug Resistance in Cancer: An Overview
2014 Standout
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
2012
Lysyl Oxidase: From Basic Science to Future Cancer Treatment
2012
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Works of Tim J. Kruser being referenced
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
2008
Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation
2017
Multidisciplinary management of colorectal brain metastases
2008
Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab
2009
Mechanisms of resistance to HER family targeting antibodies
2010
Augmentation of Radiation Response by Panitumumab in Models of Upper Aerodigestive Tract Cancer
2008